Skip to main content
OpenTrials
Completed

NCT Number: NCT02365116

Peer Mentorship to Reduce Suicide Risk Following Psychiatric Hospitalization

Every year in the United States about 1 million people make a suicide attempt and more than 38,000 die by suicide. The risk of suicide is highest among individuals with mental illness who have been hospitalized due to suicidal thoughts or behaviors, yet there are few interventions known to reduce suicide risk in this population. This study will develop and pilot test a peer mentorship intervention by which trained peer professionals will use their own personal experience with recovery from mental illness to instill hope and belongingness in high-risk patients and provide additional support to prevent future suicidal thoughts or behaviors.

The specific aims of the study are to: (1) develop a peer mentorship intervention to reduce suicide risk among patients psychiatrically hospitalized with suicidal ideation or following a suicide attempt; (2) Conduct a randomized controlled pilot study to assess the acceptability, feasibility, and fidelity of the peer mentorship intervention in preparation for a larger efficacy trial; and (3) an exploratory aim will be to measure potential mediators and moderators of intervention effectiveness in terms of belongingness, burdensomeness, and hopelessness according to the interpersonal theory of suicide.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Suicidal Ideation Behavior Behavioral Symptoms Self-Injurious Behavior Suicide

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Michigan Inpatient Psychiatry Unit, Ann Arbor, Michigan, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • are age 18 years or older
  • have medical record documentation of suicidal ideation or suicide attempt at the time of admission
  • are fluent in English

Exclusion criteria

  • substantially cognitively impaired (according to Mini-Cog)
  • unable to provide voluntary, written, informed consent for any reason (including incompetency)
  • determined by the patient's attending psychiatrist that due to the patient's psychiatric condition peer mentorship may be harmful to the patient or peer specialist (e.g., severe personality disorder, unstable paranoia)
  • already receiving or intending to receive peer mentorship (including having a sponsor from Alcoholics Anonymous) or participate in group-based peer support on a biweekly or more frequent basis
  • are receiving electroconvulsive therapy (ECT)
  • are located more than 50 miles from any of the peer specialists
  • are being discharged to a residential treatment facility

Treatment and study plan

Peer Mentorship

Behavioral

Patients who are working with a peer specialist will have their sessions audio taped and reviewed by research staff for training purposes and to ensure that peer specialists are following protocol.

Enhanced Usual Care

Behavioral

The enhancement to usual care will occur at the 3 and 6 month follow-up assessments, where participants will be assessed to determine whether they require any additional referral information for follow-up care. If referral information is indicated, the patient will be provided a list of mental health treatment providers in their area.

Primary outcomes

  1. Intervention acceptability (median number of peer mentorship contacts at 3 months post-discharge is at least 4, as well as by satisfaction questionnaires.)

    Time frame: 3 and 6 months post-baseline

    Patients' willingness and satisfaction with participating in the intervention as a measure of intervention acceptability. Measured by at least 70% of participants in both study arms completing follow-up measures at 6 months, the median number of peer mentorship contacts at 3 months post-discharge is at least 4, as well as by satisfaction questionnaires.

  2. Intervention feasibility (Study team's ability to deliver the intervention)

    Time frame: 3 and 6 months post-baseline

    Study team's ability to deliver the intervention as a measure of feasibility. Measured by at least 50% of eligible patients choosing to enroll in the study, at least 80% of participants assigned to the peer mentorship arm meeting with a peer specialist prior to hospital discharge, at least 70% of participants in both study arms completing follow-up measures at 6 months, and the study meeting its enrollment goal of 60 patients in 12 months.

Secondary outcomes

  1. Current suicidal ideation (measured by the Beck Suicide Scale (BSS)

    Time frame: 3 and 6 months post-baseline

    Patient's current suicidal ideation as measured by the Beck Suicide Scale (BSS)

  2. Peak suicidal ideation (measured by the Columbia Suicide Severity Rating Scale (CSSR-S)

    Time frame: 3 and 6 months post-baseline

    Patient's peak suicidal ideation since the last visit as measured by the Columbia Suicide Severity Rating Scale (CSSR-S)

  3. Suicide attempts (measured by the Columbia Suicide Severity Rating Scale)

    Time frame: 3 and 6 months post-baseline

    Patient's suicide attempts since the last visit as measured by the Columbia Suicide Severity Rating Scale

Sponsors and collaborators

Lead sponsor

University of Michigan

Other

Collaborators

  • National Institutes of Health (NIH)

Registry information

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Feb 18, 2015
Registry last updated
Aug 15, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.